Navigation Links
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
Date:5/21/2008

drug nomenclature by working closely with the International Nonproprietary Name Programme of WHO and various national nomenclature groups.

About Voreloxin (SNS-595)

Voreloxin (also known as SNS-595) is a novel naphthyridine analog, structurally related to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and rapid apoptosis. The topoisomerase II-associated DNA intercalation and DNA damage produced by voreloxin show greater selectivity for proliferating cells.

In nonclinical evaluations, voreloxin demonstrates broad and potent activity in tumor biopsies and in xenograft, syngeneic and drug-resistant tumor models. In addition to the REVEAL-1 Phase 2 clinical trial in elderly AML patients, voreloxin is being evaluated in combination with cytarabine in a Phase 1b clinical trial and as a single agent in a Phase 2 clinical trial in platinum-resistant ovarian cancer. In clinical trials conducted to date, voreloxin has been generally well tolerated and has shown objective responses in both solid and hematologic tumor types.

About Acute Myeloid Leukemia

AML is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The American Cancer Society estimates that over 13,000 new cases of AML will be diagnosed and approximately 8,800 deaths from AML will occur in the U.S. during 2008. AML is generally a disease of older adults and the median age of a patient with AML is about 67 years. A majority of elderly patients are not considered candidates for standard therapy or decline therapy, resulting in an acute need for new treatment options.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and c
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
2. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
3. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
4. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
5. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
(Date:1/23/2015)... 23, 2015  Mallinckrodt plc (NYSE: MNK ) ... a share repurchase program. The open-ended authorization permits the ... plc ordinary shares. "Funding additional initiatives ... as we continue to pursue a range of focused ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 2012 Star Scientific, Inc. (NASDAQ: CIGX ... Inc., announces that it has received important new research ... Sarasota, Florida. The Institute has completed a successful animal ... anatabine (patent pending), in an animal model of multiple ...
... PDII ) today announced that it will release its ... after the market close and host a conference call on ... the results.Access information:Date: , Tuesday, May 15, 2012Time:  , ... and Canada) or (706) 643-1203Conference ID number: , 72367450Live web ...
Cached Medicine Technology:Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis 2Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis 3Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis 4
(Date:1/22/2015)... January 23, 2015 Recently, Weddingshe.com has added ... and has announced its highest annual revenues in the past ... its popular glamorous wedding dresses. , According to the sales ... wedding dress promotions for them in 2015. This point can ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
(Date:12/26/2014)... It is said that nothing makes a ... the famous wedding dress supplier, shows its new selection ... gown promotion. , UWDress.com’s navy cocktail gowns are the ... in high fashion styles. Simple dresses in bright neon colors ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... a new technology that relies on thousands of synthetic molecules ... method for detecting Alzheimer,s disease with a simple blood test. ... important diseases, according to the report in the January 7th ... publication. "If this works in Alzheimer,s disease, it suggests ...
... on reactive oxygen species (ROS) ions or very small ... they damage cell structure and their potential link to stroke, ... Eli and Edythe Broad Center of Regenerative Medicine and Stem ... stem cells, the cells that give rise to neurons, maintain ...
... Spartanburg, S.C., USA, 6 January, 2010 Researchers at Wofford ... over 1000 objects, differentiating between names of objects and orders ... in Germany, who had discovered a dog that knew the ... left open as to how far a dog could go, ...
... The use of combined treatments for severe acute ... disease, resulting in shorter hospitalizations and fewer radiological ... in Clinical Gastroenterology and Hepatology , the ... Institute. In a related study, doctors found that ...
... simpler form of testing individuals with risk factors for ... the number of individuals who complete testing and learn ... Approximately 60 million Americans, one-third of the adult ... develop Type 2 diabetes in less than a decade, ...
... the most widely produced fruit in the world and ... a nutrient which could tackle the onset of vascular ... Nutrition & Food Research , reveals that an extracted ... team led by Dr Teruo Kawada, from Kyoto University ...
Cached Medicine News:Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 2Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 3Health News:Border collie comprehends over 1,000 object names 2Health News:Border collie comprehends over 1,000 object names 3Health News:Less invasive techniques help manage complications of severe pancreatic disease 2Health News:Less invasive techniques help manage complications of severe pancreatic disease 3Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 2Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 3
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... people are in need of MRI exams, ... tunnel-type scanners. They have heard of, or ... claustrophobic and noisy tubes of supercon scanners ... What people want is a patient-friendly MRI. ...
Picofluor™ Fluorometer is a lightweight, inexpensive, handheld fluorometer, configured for the fluorescent probes commonly used for nucleic acid and protein quantitation....
... a spectro-fluorometer supplied by HORIBA ... a new type of spectro-fluorometer ... various components. The flexible system ... choose components that best suit ...
Medicine Products: